A small cohort study of patients in the UK with unmethylated MGMT status showed a prolongation of 3.3 months with TTFields added to standard therapy [ 39 ], although the sample size was small and did not reach statistical significance.
← all excerpts
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
1
—
—